Tus kws kho mob
Iron Chelation - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1901 - 1910 ntawm 3685
Tus kws kho mob
Xolair® (omalizumab) - Medicaid
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Xolair® (omalizumab) - Commercial
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P7-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P8-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Sleep Management Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P9-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective April 4, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2022
Tus kws kho mob
QP12-22 MHCP Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 09, 2022
Tus kws kho mob
QP13-22 Commercial Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 09, 2022
Tus kws kho mob
Substance Use Disorder Concurrent Request Form (PDF)
Tus kws kho mob
Parathyroid Hormone Analog for Osteoporosis - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2025